Sorafenib Inhouse Impurity E
✓
100% accuracy
of data
24/7 scientific
support
⬡
0% tolerance in
quality of product

Stock Locations

  • New Jersey, USA
  • Czech Republic, EU
  • Mumbai, India

* Stock subject to availability.

Documentation

Download MSDS

Download Sample COA

Includes: HPLC, MASS/LC-MS, 1H NMR, FT-IR, Potency, Structure Elucidation Report (SER), and additional analytical data depending on the product.

284670-98-0Sorafenib Inhouse Impurity E

● In Stock

Catalogue No.:VE008168
CAS No.:284670-98-0
Mol. Formula:C27H24N6O5
Mol. Weight:512.52 g/mol

Additional information on CAS 284670-98-0

Parent drug

Sorafenib

IUPAC Name

N, N’-Bis[4-[2-(N-methylcarbamoyl)-4-pyridyloxy]phenyl]urea

Synonyms

N/A

Smiles

CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC=C(C=C3)OC4=CC(=NC=C4)C(=O)NC

Description

Sorafenib Inhouse Impurity E (CAS No: 284670-98-0) Or N, N'-Bis[4-[2-(N-methylcarbamoyl)-4-pyridyloxy]phenyl]urea, Sorafenib Inhouse Impurity E is an impurity of Sorafenib, Sorafenib is an orally active multikinase inhibitor, which is used for the treatment of renal cell carcinoma.

Request a Quote

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
Products quotation
Name
Url